|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 519.60 INR | -0.69% |
|
-2.08% | +17.73% |
| 23/05 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 22/05 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 3.68TCr 39Cr 34Cr 31Cr 29Cr 54Cr 55Cr 368.45Cr 144.26Cr 1.83TCr 144.9Cr 141.73Cr 6.15TCr | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 3.89TCr 41Cr 35Cr 33Cr 30Cr 57Cr 58Cr 389.53Cr 152.51Cr 1.93TCr 153.18Cr 149.83Cr 6.5TCr | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -0.69% | ||
| 1 week | -2.08% | ||
| Current month | +11.89% | ||
| 1 month | +11.89% | ||
| 3 months | +33.47% | ||
| 6 months | +38.78% | ||
| Current year | +17.73% |
| 1 week | 517.8 |  | 548.55 |
| 1 month | 455.3 | | 685.95 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.69% | -2.08% | -16.15% | +31.53% | 39Cr | |
| -4.55% | -2.61% | +51.95% | +151.91% | 1,03000Cr | |
| -3.66% | -1.33% | +52.95% | +46.62% | 62TCr | |
| -2.24% | +0.19% | +35.97% | +70.64% | 45TCr | |
| -2.29% | +1.12% | +36.13% | +31.18% | 35TCr | |
| -2.28% | -0.69% | +33.42% | +40.48% | 30TCr | |
| -3.15% | +0.25% | +10.63% | +15.03% | 27TCr | |
| -2.12% | +3.31% | +1.82% | -37.38% | 23TCr | |
| 0.00% | +4.34% | +28.63% | +64.00% | 21TCr | |
| -1.09% | +0.32% | +14.40% | +70.80% | 16TCr | |
| Average | -1.72% | +4.46% | +24.97% | +48.48% | 36.13TCr | |
| Weighted average by Cap. | -1.63% | +4.87% | +37.83% | +72.19% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.11TCr 22Cr 19Cr 18Cr 16Cr 31Cr 32Cr 211.15Cr 83Cr 1.05TCr 83Cr 81Cr 3.53TCr | 2.2TCr 23Cr 20Cr 19Cr 17Cr 32Cr 33Cr 220.24Cr 86Cr 1.09TCr 87Cr 85Cr 3.68TCr |
| Net income | 137.52Cr 1.44Cr 1.25Cr 1.16Cr 1.07Cr 2.02Cr 2.05Cr 14Cr 5.39Cr 68Cr 5.41Cr 5.29Cr 229.69Cr | 252.84Cr 2.65Cr 2.3Cr 2.14Cr 1.97Cr 3.71Cr 3.78Cr 25Cr 9.9Cr 125.57Cr 9.95Cr 9.73Cr 422.29Cr |
| Net Debt | 370.19Cr 3.88Cr 3.37Cr 3.13Cr 2.88Cr 5.43Cr 5.53Cr 37Cr 14Cr 183.86Cr 15Cr 14Cr 618.29Cr | 210.67Cr 2.21Cr 1.92Cr 1.78Cr 1.64Cr 3.09Cr 3.15Cr 21Cr 8.25Cr 104.63Cr 8.29Cr 8.11Cr 351.86Cr |
Employees
2,780
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | ₹519.60 | -0.69% | 1,281 |
| 30/26/30 | ₹523.20 | -1.97% | 5,137 |
| 29/26/29 | ₹533.70 | -0.14% | 2,124 |
| 28/26/28 | ₹534.45 | -1.66% | 2,04,402 |
| 27/26/27 | ₹543.45 | +0.78% | 3,313 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
